Intas Pharmaceuticals
Avinash Patel is a Research Associate (Executive) in the Analytical Development Laboratory at Intas Pharmaceuticals since April 2024. Prior to this role, Avinash worked as an Executive in Quality Control at Cadila Pharmaceuticals Limited from August 2022 to April 2024 and served as an Officer in Quality Control at Zydus Group from August 2019 to August 2022. Avinash holds a Master of Science in Organic Chemistry from the Department of Chemistry at Gujarat University, completed in 2019, and a Bachelor of Science in Chemistry from C.U.Shah Science College, Gujarat University, obtained in 2017.
This person is not in the org chart
Intas Pharmaceuticals
2 followers
Intas Pharmaceuticals Ltd. is an India-based pharmaceutical formulation development, manufacturing and marketing company. The Company offers products for the treatment of cardiovascular system (CVS), diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management, as well as other therapeutic segments. Its pharma products include ACUTROL-400, ADAPEN GEL, ADIFLOX, ALZIL 10, ALZIL M 10 and AMITONE 10. The Company's biologics products include Albucel 20%, Epofit, Erykine, Factocel VIII, MabTas, Neukine and Neupeg. It range of products for animal health includes AC-Vet, AC-Vet Forte, AC-Vet Max, Alzonic, Anistamin, Benezepril, Bufzone, Calshakti Platina and Carprofen Inj. The Company offers approximately 10 biologic products and is engaged in research and development in chronic disease areas, such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma derived product based therapies.